Watch List: 22nd Century Group, Inc. (NYSEMKT:XXII), Eaton Vance New York Municipal Income Trust (NYSEMKT:EVY), Neogenomics Inc. (NASDAQ:NEO), Nxstage Medical, Inc.

On 18 February, 22nd Century Group, Inc. (NYSEMKT:XXII) announced that the Company filed its 2015 Annual Report on Form 10-K with the U.S. Securities and Exchange Commission.

22nd Century Group, Inc. (NYSEMKT:XXII) belongs to Healthcare sector. Its weekly performance is -5.05%. On last trading day company shares ended up at $0.94. 22nd Century Group, Inc. (NYSEMKT:XXII) distance from 50-day simple moving average (SMA50) is -21.86%.

On 26 February, Eaton Vance New York Municipal Income Trust (NYSEMKT:EVY) announced the final results of its tender offer (the “Tender Offer”) ending February 23, 2016 to repurchase up to 100% of its outstanding auction preferred shares (“APS”). For each Fund other than Eaton Vance Municipal Income Trust (“Muni Income Trust”), the Tender Offer is at a price per share equal to 95.5% of the liquidation preference per share (or $23,875 per share), plus any accrued but unpaid APS dividends. For Muni Income Trust, the Tender Offer is at a price per share equal to 94.5% of the liquidation preference per share (or $23,625 per share), plus any accrued but unpaid APS dividends.

Eaton Vance New York Municipal Income Trust (NYSEMKT:EVY) shares moved up 0.29% in last trading session and ended the day at $14.04. EVY Gross Margin is 79.30% and its return on assets is 12.20%. Eaton Vance New York Municipal Income Trust (NYSEMKT:EVY) quarterly performance is 4.21%.

Neogenomics Inc. (NASDAQ:NEO) will be announcing its Q415 earnings results on Tuesday, March 1st. Analysts expect the company to announce earnings of $0.01 per share and revenue of $26.46 million for the quarter.

On 26 February, Neogenomics Inc. (NASDAQ:NEO) shares moved up 3.48% and was closed at $6.25. Neogenomics Inc. (NASDAQ:NEO) year to date (YTD) performance is -20.58%.

Nxstage Medical, Inc. (NASDAQ:NXTM) said that, its during the 2016 Annual Dialysis Conference (ADC) in Seattle from February 27– March 1, NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, will be presenting abstracts highlighting benefits of its Nx2me® Connected Health technology as well as those seen in programs with increased home hemodialysis (HHD) training volume.

Nxstage Medical, Inc. (NASDAQ:NXTM) ended the last trading day at $15.17. Company weekly volatility is calculated as 4.75%. Nxstage Medical, Inc. (NASDAQ:NXTM) showed a weekly performance of 7.36%.

On 16 February, Penn West Petroleum Ltd. (NYSE:PWE) has reached agreements to settle a bevy of class-action lawsuits stemming from accounting. The settlement in the Canadian and U.S. cases will be fully funded by the company’s insurance, meaning its cash resources and financial position won’t take a hit.

Penn West Petroleum Ltd. (NYSE:PWE) belongs to Basic Materials sector. Its weekly performance is 2.74%. On last trading day company shares ended up at $0.97. Penn West Petroleum Ltd. (NYSE:PWE) distance from 50-day simple moving average (SMA50) is 21.30%.

Leave a Reply

Your email address will not be published. Required fields are marked *